Delivery Order SPE2DB24D2205-SPE2DB25FDTXV

Award Date 11/12/24
Potential Completion Date 11/13/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,796.51 Firm Fixed Price delivery order contract is for the supply of 4566848926 CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,588.42 firm fixed-price delivery order is for the supply of 4567796165 CLOBAZAM 10 MG TABLET 100S, with a performance period through April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,930.95 firm fixed-price delivery order is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,553.82 firm fixed-price delivery order is for the supply of 4562781064 - CLOBAZAM 10 MG TABLET 100S, with a completion date of November 13, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $7,233.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4567361463 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a period of performance through February 25, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,898.15 Firm Fixed Price delivery order is for the supply of 4567678619 - CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a completion date of March 25, 2025 and was awarded on March 24, 2025. This contract is not designated with a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,143.18 firm fixed-price delivery order is for the supply of 4,566,066,813 units of CLOBAZAM 10 MG TABLET, an anti-seizure medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award, valued at $1,977.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order, is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,541.32, is for the delivery of 4566444918 CLOBAZAM 10 MG TABLET 100S. It is a Firm Fixed Price Delivery Order contract with a completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,111.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, and is designated as a Firm Fixed Price Delivery Order with a completion date of February 21, 2025. The contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTXV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,309.74 Firm Fixed Price Delivery Order contract is for the supply of 4566401651 - CLOBAZAM 10 MG TABLET 100S, with a period of performance through November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical commodities. This contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/11/25, 10:20 AM